Skip to main content
. 2020 Nov 21;12(11):1125. doi: 10.3390/pharmaceutics12111125

Table 5.

Molecular targeting and drug/gene-complexed bubble for BBB opening and therapeutic purpose.

Ref Core Shell Molecular Targeting Drug/Gene Embedded in the Agent
[86] air polymer NA quercetin-modified sulfur nanoparticles-loaded bubble
[88] C5F12 polymer des-octanoyl ghrelin-conjugated bubble TGFβ1 inhibitor (LY364947)-loaded bubble
[89] SF6 lipid NA GDNFp/BDNFp-loaded liposome bound to bubble
[90] SF6 lipid NA ultrasound-sensitizing dye-incorporating nanoparticles bound to bubble
[110] C3F8 lipid NGR-conjugated (targeting)/shBirc5-loaded (gene) liposome bound to bubble
[104] C3F8 lipid anti-VEGFR2 antibody-conjugated bubble pLUC / pHSV-TK/GCV-loaded bubble
[109] C3F8 lipid NA SPIO-DOX-conjugated bubble
[111] C3F8 lipid NA GDNFp-loaded cationic bubble
[112] C3F8 lipid NA pDC315/Nrf2-loaded bubble
[107] C3F8 lipid folate-conjugated bubble pLUC-loaded bubble
[105] C3F8 lipid NA pPrestin-loaded bubble
[106] C3F8 lipid NA boron-containing polyanion nanoparticles coupled with cationic bubble
[125] C3F8 lipid NA PSPIO-GDNFp-loaded bubble
[113] C3F8 lipid phosphatidylserine nanoparticles-microbubble complex

TGFβ1: transforming growth factor; GDNFp: a glial cell line-derived neurotrophic factor plasmid DNA; BDNFp: brain-derived neurotrophic factor plasmid DNA; NGR: Asn-Gly-Arg peptide; shBirc5: short hairpin RNA-Birc5 gene; VEGFR2: vascular endothelial growth factor receptor 2; pLUC: plasmid DNA encoding luciferase gene; pHSV-TK/GCV: plasmid DNA encoding herpes simplex virus type 1 thymidine kinase/ganciclovir gene; SPIO-DOX: superparamagnetic iron oxide-doxorubicin complex; pDC315/Nrf2: plasmid DNA encoding DC315-nuclear factor E2-related factor 2; pPrestin: plasmid DNA encoding Prestin protein; PSPIO-GDNFp: superparamagnetic iron oxide coated with cationic polyethylenimine conjugated with plasmid DNA encoding glial cell line-derived neurotrophic factor; NA: Not applicable).